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 Myopia, or nearsightedness, affects approximately 25%
of the adult population in the United States [1-5], and is in-
creasing in prevalence. High-grade myopia (<5 diopters) af-
fects 4.5% of the U.S. population 40 years and older [5], and
is a major cause of legal blindness in many developed coun-
tries [6-8], as it predisposes individuals to premature cataracts,
glaucoma, retinal detachment, and macular degeneration [9-
14]. Though myopia affects a significant proportion of the
population in many countries, it is reaching epidemic propor-
tions in some Asian countries. Taiwan, for example, has a
myopia prevalence of 84% among 16- to 18-year-old high
school students and a high-grade myopia prevalence of 21%
among 18-year-old students [15].
Determining the role of genetic factors in the develop-
ment of non-syndromic myopia has been influenced by the
high prevalence, genetic heterogeneity, and clinical spectrum
of this condition, as well as possible modulating environmen-
tal effects. However, in the past few years, considerable
progress has been made. An X-linked recessive form of myo-
pia was designated the first myopia locus (MYP1, OMIM
310460) on chromosome Xq28 [16]. Reanalysis of this Dan-
ish pedigree and another X-linked pedigree of Danish descent
suggests that this disease locus involves a cone dysfunction
and not simple myopia [17]. By studying several medium to
large multigenerational families with autosomal dominant
(AD) high-grade myopia, we have found significant linkage
at chromosome 18p11.31 (MYP2, OMIM 160700) [18], chro-
mosome 12q23.1-24 (MYP3, OMIM 603221) [19], chromo-
some 17q21-23 (MYP5, OMIM 608474) [20], and most re-
cently at chromosome 2q37.1 (MYP12, OMIM 609994) [21].
In addition, other research groups studying AD high-grade
myopia have found suggestive linkage on chromosome 7q36
(MYP4, OMIM 608367) [22] and significant linkage to chro-
mosomes 7p15.3 [23], chromosome 15q12-13 [24], and chro-
mosome 4q22-q27 (MYP11, OMIM 609994) [25]. Two re-
cent studies have determined loci for common myopia: one in
an Ashkenazi Jewish cohort with linkage to chromosome
22q12 (MYP6, OMIM 608908) [26], chromosome 1p36
(MYP14, OMIM 610320) [27], and another in English dizy-
gotic twins with linkage to the PAX6 gene region on chromo-
some 11p13 (MYP7, OMIM 609256), chromosome 3q26
(MYP8, OMIM 609257), 4q12 (MYP9, OMIM609257), and
8p23 (MYP10, OMIM 609259) [28]. Most recently X-linked
recessive myopia was mapped to Xq23-25 (MYP13, OMIM
300613) region of the X-chromosome [29].
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Purpose: Myopia is a common, complex disorder, and severe forms have implications for blindness due to increased risk
of premature cataracts, glaucoma, retinal detachment, and macular degeneration. Autosomal dominant (AD) non-syndromic
high-grade myopia has been mapped to chromosomes 18p11.31, 12q21-23, 17q21-23, 7q36, 2q37.1, 7p15.3, 15q12-13,
3q26, 4q12, 8p23, 4q22-q27, 1p36, and Xq23-q25. Here, we demonstrate evidence of linkage for AD non-syndromic
high-grade myopia in a large Hutterite family to a locus on chromosome 10q21.1.
Methods: After clinical evaluation, genomic DNA was genotyped from 29 members of a Hutterite family from South
Dakota (7 affected). The average refractive error of affected individuals was -7.04 diopters. Microsatellite markers were
used to exclude linkage to the known AD nonsyndromic high-grade myopia loci as well as to syndromic high-grade
myopia loci. A genome screen was then performed using 382 markers with an average inter-marker distance of 10 cM
followed by fine-point mapping in all regions of the genome that gave positive LOD scores. SimWalk2 software was used
for multipoint linkage based on AD and autosomal recessive (AR) models with a penetrance of 90% and a disease allele
frequency of 0.001.
Results: A maximum multipoint LOD score of 3.22 was achieved under an AD model at microsatellite marker D10S1643.
Fine point mapping and haplotype analysis defined a critical region of 2.67 cM on chromosome 10q21.1. Haplotype
analysis demonstrated two distinct haplotypes segregating with high-grade myopia, indicative of two distinct mutations
occurring in the same gene.
Conclusions: We have identified a presumptive myopia locus for high-grade myopia based on linkage and haplotype
analysis.
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229Herein, we study high myopia in a group of Hutterites
from South Dakota. The Hutterites were originally refugees
from the Anabaptists from Switzerland, Germany, and the Tyrol
who settled in Moravia and were united under Jacob Hutter’s
leadership in the 1500s. The four most important Hutterian
tenets were adult baptism of believers, community of goods,
nonresistance, and the separation of church and state. Due to
religious persecution, the Hutterites moved frequently through
the centuries, and today about 25% of Hutterites live in the
United States. The Hutterites have an internal educational sys-
tem based within their colonies, starting instruction at age 6
years, and ending at 8th grade (age 13 years). In this study, we
exclude linkage to known myopia loci, and report significant
linkage of AD nonsyndromic high-grade myopia to a presump-
tive locus on chromosome 10q21.1 for a large, multi-genera-
tional Hutterite family. To our knowledge, this is the first time
that high myopia has been studied in a genetically isolated
group.
METHODS
Subject data collection:  A large Hutterite family from South
Dakota (Pedigree MYO-101) with 29 members (7 affected)
consented to participate in the study. This study was approved
by the Institutional Review Board of The University of Min-
nesota and The Children’s Hospital of Philadelphia, and ad-
hered to the tenets of the Declaration of Helsinki. This family
was selected based on the presence of affected individuals in
multiple generations. Individuals with high-grade myopia,
defined as a spherical refractive error of <-5.00 diopters (D)
in at least one eye, were considered “affected” and individu-
als with a spherical refractive between -2.00 and -5.00 D in at
least one eye were considered “unknown”, as they had an in-
creased likelihood of developing high-grade myopia. All other
individuals (spherical refractive errors >-2.00 D in both eyes)
were considered “not affected”. No participant had known
ocular disease or insult that could predispose to myopia or
any known genetic syndrome associated with myopia. Glau-
coma, keratoconus, corneal thinning, lenticonus, and dislo-
cated lens were absent in study participants. The family did
not display any other systemic genetic traits.
A comprehensive ophthalmic examination and blood col-
lection was performed by one of the authors, TLY, as previ-
ously described [18]. Details of the ophthalmic examination
are summarized in Table 1. DNA was isolated from peripheral
blood lymphocytes using standard techniques (Gentra Sys-
tems, Minneapolis, MN).
Candidate loci screening:  Initially, we screened 15 can-
didate gene loci using intragenic and flanking microsatellite
©2007 Molecular Vision Molecular Vision 2007; 13:229-36 <http://www.molvis.org/molvis/v13/a26/>
TABLE 1. CLINICAL CHARACTERISTICS OF PEDIGREE MYO-101
                                Age    Age
                    Myopia      at      at    Refractive Error   Refractive Error     Ocular
Subject   Gender   phenotype   onset   exam          OD                 OS            history
-------   ------   ---------   -----   ----   ----------------   -----------------   ---------
7242      F        NA          40      56      +0.25 +0.75x79     +0.25 +0.50x77        ---
7243      M        UK          14      32      -2.25 +0.25x90     -1.75 sphere          ---
7244      M        NA          ---     19      -0.25 sphere            Plano            ---
7245      F        A           15      22      -3.75 +0.75x90     -5.25 +1.25x90        ---
7246      F        UK          14      17      -3.00 sphere       -2.25 +0.25x110       ---
7247      F        UK          14      15      -2.00 sphere       -1.50 +1.00x80        ---
7248      M        UK          10      21      -2.00 +0.50x176    -2.75 +1.50x165       ---
7249      M        NA          30      54      +2.50 sphere       +2.50 sphere          ---
7251      F        A           6       9       -5.50 +0.75x95     -6.00 +1.25x90        ---
7252      F        A           7       12      -8.00 +1.25x90     -6.50 +0.25x90        ---
7253      F        A           14      60     -11.25 +0.75x105    -12.25 +0.75x45       ---
7254      M        A           16      31      -5.50 +0.50x155    -9.00 +3.50x60        ---
7255      M        NA          45      48      -0.50 +0.25x61     -0.25 +0.50x90        ---
7256      M        NA          ---     32      -0.50 sphere       +0.25 sphere          ---
7257      M        NA          ---     26      -0.75 +1.00x75     -0.25 +0.25x95        ---
7258      F        UK          14      33      -3.00 +1.25x90     -1.25 +0.75x90        ---
7259      M        NA          17      33      -1.25 -1.25x125    -1.50 -0.75x50        ---
7260      M        NA          30      69      +0.50 +1.00x9      -1.25 +0.50x16        ---
7261      F        NA          15      59      +1.25 +0.25x2      +1.00 +0.50x165       ---
7262      M        NA          15      59      -0.75 +1.00x8      -0.25 +0.50x174       ---
7263      M        UK          10      24      -1.00 +0.50x75     -2.50 +1.25x80        ---
7264      F        UK          19      47      -2.75 +1.25x37     -2.00 +0.75x150       ---
7266      F        UK          15      55      -3.00 +1.25x30     -2.5 +0.75x145        ---
7268      F        UK          9       54      -4.25 +2.5x85      -3.25 +2.75x70        ---
7270      M        NA          ---     9            Plano              Plano            ---
7272      M        A           13      31      -4.25 +1.00x180    -4.25 +1.00x164    s/p LASIK
7274      M        A           14      37      -6.75 +3.75x90     -4.75 +1.75x75        ---
7275      M        NA          50      61      +0.5  +0.25x140      Plano+0.75x170      ---
7277      M        NA          ---     35      +0.25 +0.50x79     +0.25 +0.25x105       ---
Clinical characteristics of pedigree MYO-101. A=Affected, NA= Not Affected, UK= Unknown, M= Male, F=Female, OD= right eye, OS=
left eye, Plano=no refractive error.
230markers. These loci included all of the known myopia loci
mentioned earlier, except for Xq28, as there was no evidence
for an X-linked mode of inheritance. The other candidate re-
gions screened were syndromic loci with high-grade myopia
as a consistent phenotype, including Stickler syndrome types
1, 2, and 3; Marfan syndrome; juvenile glaucoma; and
Knobloch syndrome. Of these syndromes, all are inherited in
an autosomal dominant fashion except for Knobloch syndrome,
which is autosomal recessive (AR). As there were many un-
known refractive errors (family members not examined or
genotyped) in the older generations, we were initially uncer-
tain whether the mode of inheritance was AD or AR.
Genotyping:  Genome screening was performed on Pedi-
gree MYO-101 using 382 microsatellite markers from a com-
mercial set (ABI Prism Linkage Mapping Set MD-10; Ap-
plied Biosystems, Inc., Foster City, CA) with an average in-
ter-marker distance of 10 cM. The PCR reactions were pre-
pared in 10 µl volumes in 96-well plates with 6 µl of True
Allele PCR Premix, 1 µl primer, 1 µl sterile H2O, and 2 µl of
3 µg/µl DNA. The conditions recommended by Applied
Biosystems were optimized for our PCR machines. The
fluorescently labeled PCR products were diluted and pooled
(3-7 markers/pool) and run on an automated DNA sequencer
(ABI Prism 3730 DNA Analyzer; Applied Biosystems).
GeneMapper Software Version 3.0 (Applied Biosystems) was
used for automated allele calling, visualization of alleles, and
manual genotype verification. After the initial genome screen,
markers from the ABI Prism Linkage Mapping Set HD-5 (with
an average inter-marker distance of 5 cM) and additional cus-
tom-made markers selected from publicly available genetic
maps [30,31] were added in all regions with positive LOD
scores. Inter-marker recombination frequencies and marker
order were obtained from the standard marker databases of
the Marshfield Center for Medical Genetics, Gènèthon, and
the UCSC (University of California Santa Cruz) database.
Linkage analysis:  Mendelian error checking was per-
formed using PEDMANAGER Version 0.9 software. Mega2
Version 3.0 software [32] was used to create the necessary
files required for statistical analysis. SimWalk2 Version 2.89
software [33-35] was used for multipoint linkage analysis
based on both AD and AR models, as the mode of inheritance
was uncertain. A 90% penetrance and a myopia allele frequency
of 0.001 were used. Marker allele frequencies were estimated
by maximum likelihood based on our pedigree data. Two-point
linkage analysis could not be performed because the available
linkage analysis programs were not capable of handling the
large size and complexity (many loops) of this pedigree.
Positional candidate gene mutation screening:
Protocadherin 15 (PCDH15) contains 33 exons and encodes a
protein of 1,955 amino acids with a molecular mass of about
216 kDa [36]. ZW10 interactor (ZWINT) contains 9 exons and
encodes a protein of 277 amino acids with a molecular mass
of 32 kDa [37]. We designed and optimized 36 sets of forward
and reverse primer pairs for PCDH15 and 8 for ZWINT. The
primer pairs were constructed to extend 50 to 200 bp beyond
each intron-exon boundary (Table 2). For each amplimer, PCR
was performed on 150 ng of participant genomic DNA using
Taq polymerase (AmpliTaq Gold; Roche Molecular Systems,
Inc., Branchburg, NJ) at 55 °C annealing temperature. Ampli-
fied products were separated by agarose gel electrophoresis
and visualized by staining with ethidium bromide. Two highly
myopic family members (7254 and 7272) were screened, along
with 2 unaffected (average spherical refractive error=-0.31 D)
family members (7256 and 7257) and 1 external control
(C009), a United States caucasian male with no refractive er-
ror. If a polymorphism appeared to follow affection status,
four additional affected individuals (7245, 7251, 7252, and
7274) were screened for that polymorphism in an attempt to
confirm or exclude it as a myopia-causative mutation.
Amplicons were sequenced using the BigDye® Terminator
v3.1 Cycle Sequencing Kit and were run on an ABI 3730 DNA
Analyzer (Applied Biosystems, Foster City, CA). Chromato-
grams were trimmed for quality and aligned with reference
gene sequences from NCBI using Sequencher™ (Gene Codes,
Ann Arbor, MI).
RESULTS
 A multi-generational Hutterite family from South Dakota
(MYO-101) with high-grade myopia was identified and char-
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TABLE 2. PRIMERS DESIGNED FOR MUTATION SCREENING
  Exon           Forward Primer                Reverse Primer
--------   ---------------------------   ---------------------------
   PCDH15
1          TCACTTGCAATCATTACTACTCTAT     GGCTGACGAACACAGTACAATA
2          AAAAATCCTGGCTCGCTCTA          AATGTGGCACAGGTAATTAACTATG
3          TTATTCCAAGTAAAGCATGA          TTTTCCTTTTTAAATATTAATATAC
4          AAATGAGTTAAAGAAACTGTTGT       TATTTTCTGTCTTATGCTAGATATA
5          GTTTTCTTGATATTTCTAAACAGTT     TGTACTGAATGAACGAGTGCT
6          AATAATAGTATCATTACTAATCTGG     GAGCTGATTTTTATGCTGTAACA
7          ATGAAGAAGTGAGTGGCACA          TTCTATTTTCAGATGATAAGCATGT
8          AAAATAAAATAACCATGTTGGACT      TTTTTGTTGTTGTTTTTTGAGACTG
9          AAATATTTCCTTGGAATTGA          TGAGTTTACTGTCTCAGACGTTATA
10         TAACATAAAACTGCCTACAGTAGCG     TTTGTTCCTCAGCTGATGAAGGG
11         TTAATTCTCTCTTCTCTAGCTTATG     ATTAGTTAAAAAGAGAACCCTATA
12         CCAGACATCTCTTTCAGTTCCATAC     TCTTAATACTTTCACGTGGAT
13         TAATTTCTTCATGAGCATATCGTAT     CCTTTCAAATTGTAAGATTACCTG
14         AAGAATACTTGCCGCGCTTC          TTGTTGGGGGAAAAAACGACATGGT
15         CAGATGGAATTTTCATTCACTAGAG     AACAACTGAATAAACAATGCAGTC
16         AGAAAACAGAAAGGGAAGTACAAC      GATACGAAATGTTTGATTTTACACC
17         TGATTACTGAGAGGGGAAA           TGTCAAGTCAAAGGTTGCAGC
18         TTCAGATAGACAAATGCCAGAA        AGTCTTGAAGAATATCCAGCACA
19         ATTGTCATTGTCATTTCCTCCTT       GGCACACAAACCCTAATAGCA
20         GTCCTCGTTAAATTGATGCTGT        TTGGAAAATCTATGTTATGGGTC
21         AATTGAGAGGATGGAAGGCT          TTGCTGTCTTGTGATTCGGTC
22         CCCAAAGCAACCATTAATTTTTC       ATGAGGATAGAGATCAAAACGCA
23         CACCTGGTAGGCAGTGAGGAAAT       TTGAAACCCCAAAATATAATGT
24         ATGAATGTGTGAGGGCAGAGGGT       CAAATGAGGAAAAGGGCAAGGT
25         TTAGCGAAGTATTGATGTTGA         TCCCAAGGTTTATCCAGAG
26         AAGCATCATTATCAGTGTCCC         CCTACTGGAGGAATACAAACC
27         CCCCTCCGTCTAGGCTACTGATA       AAACTGAAAACACTGACCTATGGCT
28         GTAGGGAAGAGGTAATGTGGG         AGACACTGAGGGCTCCAA
29         GGCTGTCATCATTTTTCATTT         TTCAGTAACTATTTGGTGGGT
30         GCTTGTGTTTCAATTAGAGAA         CGCAAAGCCATGTTAC
31         GAATGACTCTAACGGTAACGAT        TGGAAGCTATAGGCAAACTATCT
32         CCTGTGGGGATGCTTTTGTAA         AATTTCTGGTTTGGTTTTGGC
33-1       AACTTGTTTCCTTACATTTCA         CCTTGCCTTATTTCCT
33-2       AAGAGGTAGCAGCAATCCATT         CGGCAGGCATCAAGTT
33-3       CCCTCCACCTCCTTCAG             TGGTTTAAGTTGGGTATCTAA
33-4       TTTTAGTGGGAATATGTGGG          AAAAAATTTAAATTAGGGAGATGAT
   ZWINT
1          GTGGATGTGGGGAGCGGCGAACGG      AAGAACTTCCACAGGCGCGCGGTCGAG
2 and 3    GTCTTCAGAAGCCAAGGGGTCG        CCCTGCTGATTTTCCTTTTGGCACGTA
3 and 4    GGCCATTTGTTTCTACAGATAAGCAAG   GTGGTGGTATGTACAAGATGAGAGCGA
5          TCAAAGGAGGAAGCAAAACGGTTTTC    CCAAGGTACACCCAGGGGTCTTGAGTA
6 and 7    CAAATTTACATCTCCAGCAGGTTGTAG   GCAAGAATGCCTCACCCTAGAAC
8          GAGCTCACTGTTATAATTCTGGTTCAC   AGGTAAATGAGAGATGGAACAGG
9a         CTTTAAATAACTTGAGACATTGCTAAC   TAATAAACTTTGAAATTTGGTGAGT
9b         AAATGCATTCTTTCCAAACCTATGTGA   GGTTTGAACACAGGGTGTGCAG
Forward and reverse primers designed for PCDH15 and ZWINT for
mutation screening.
231acterized (Figure 1). The average spherical refractive error of
affected individuals of Pedigree MYO-101 (excluding 7272,
who had only post-LASIK refractive error information avail-
able) was -7.04 diopters (range, -3.75 to -12.25). Although we
were not able to obtain pre-LASIK refractive error informa-
tion for individual 7272, we made an assumption that he was
an affected individual for purposes of analysis based on his
self-report that he had twice the degree of myopia in diopters
prior to his surgery. Two patients from family 101 (7245 and
7274) were anisometropic, with one highly myopic and one
moderately myopic eye. The average spherical refractive er-
ror for “unknown” individuals was -2.39 D. All known
syndromic and non-syndromic myopia loci were excluded in
this family. The LOD scores at q=0.0 were as follows: D18S63
(MYP2), -5.232; D12S78 (MYP3), -0.221; D7S2465 (MYP4),
-5.781; D17S944 (MYP5), -3.418; D22S280 (MYP6), -0.960;
D11S904 (MYP7), -0.979; D2S206 (2q37.1), -2.006; D7S507
(7p15.3), -7.573; D15S165 (15q12-13), -3.969; D12S85 (Stick-
ler syndrome type 1), -4.652; D1S206 (Stickler syndrome type
2), -1.175; D6S276 (Stickler syndrome type 3), -2.788;
D15S117 (Marfan syndrome), -5.464; D1S218 (juvenile glau-
coma), -3.131; D21S1897 (Knobloch syndrome), -8.724.
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Figure 1. Pedigree MYO-101 with familial high-grade myopia.  Circles and squares indicate females and males, respectively, while solid
symbols show affected individuals. The alleles for the most informative polymorphic markers are shown for each studied individual. Haplotypes
were constructed based on the minimum number of recombinations between these markers. The solid and crosshatched bars indicate the two
affected haplotypes.
232The multipoint analysis for the initial 10 cM genome
screen resulted in no LOD scores >1.00 under an AR model.
However, under an AD model, the multipoint linkage analysis
resulted in four LOD score peaks above 1.00, occurring on
chromosomes 1p36.32-1p36.31 (LOD=1.207), 1p36.11
(1.131), 9p24.1 (1.095), and 10p11.22-10q11.23 (2.108). Ad-
ditional flanking microsatellite markers were then genotyped
in all of these regions. The LOD scores for the chromosomes
1p and 9p regions reduced or increased negligibly. Haplotype
analysis of the 1p36.11 and the 9p24.1 region did not reveal a
consistent haplotype segregating with affected individuals.
Haplotype analysis of the 1p36.32-1p36.31 region (max LOD
score with additional markers =1.330) revealed a consistent
affected haplotype in one branch of the family, but not in the
other branch. However, on chromosome 10, the additional
markers downstream of the initial 10p region produced posi-
tive LOD scores without an increase in the maximum
multipoint LOD score. Additional markers were used in this
region, and yielded a multipoint LOD score under an AD model
of 3.22 at marker D10S1643 on chromosome 10q21.1. The
one-unit support interval ranged from marker D10S539 through
marker D10S1767, a 2.67 cM region (Figure 2 and Figure 3).
Haplotype analysis correlated well with the multipoint link-
age results, as unaffected individual 7257 had a recombina-
tion event either between markers D10S220 and D10S539 or
between markers D10S539 and D10S1643 (Figure 1). It is
impossible to determine where the recombination event oc-
curs due to an allele that is common to the affected and unaf-
fected haplotypes at marker D10S539. Thus, this unaffected
individual has the affected haplotype upstream of D10S539,
excluding this region from containing the disease gene.
Interestingly, haplotype analysis also revealed two dis-
tinct haplotypes segregating with high-grade myopia (Figure
1), designated in solid black and in crosshatching. This im-
plies that either the mutation is old and has recombined into
different genetic backgrounds (haplotypes), or two distinct mu-
tations are responsible for the high-grade myopia seen in this
family [38]. Upon inspection of the pedigree, it is evident that
there are two distinct branches joined by marriage, making
the possibility of two distinct mutations likely. In addition to
the seven “affected” individuals, three “unknown” individu-
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Figure 2. Multipoint LOD score
data for pedigree MYO-101 for
chromosome 10q21.1 with mark-
ers labeled along the X-axis.  LOD
scores were plotted against marker
distance in centiMorgans (cM).
Figure 3. Schematic representation of a linkage map of microsatillite
markers located at 10q21.1.  The mapping order and genetic dis-
tances (in centiMorgans [cM]) were primarily obtained from the hu-
man genetic map of the Marshfield Center for Medical Genetics.
The bold segment denotes the linked interval determined by multipoint
linkage and haplotype analysis.
als [7243, 7248, and 7268 (average spherical refractive error
of -2.72 D)], as well as one unaffected individual (7242), car-
ried either one of the affected haplotypes. Thus, the mutation(s)
appear to show incomplete penetrance.
Two known genes were identified within the 2.67 cM re-
gion: protocadherin 15 (PCDH15) and ZW10 interacter
(ZWINT). Direct sequencing of these two genes identified a
233total of 23 polymorphisms, none of which segregated with the
affection status (Table 3). There were 21 polymorphisms iden-
tified in PCDH15; 17 intronic, 2 missense, and 2 silent, out of
which 13 were novel. There were 2 identified intronic poly-
morphisms in ZWINT, one of which was novel. All 14 novel
polymorphisms have been submitted to the National Center
for Biotechnology Information (NCBI) dbSNP database.
DISCUSSION
 This study identifies a novel autosomal dominant locus for
high-grade myopia and provides additional evidence for the
genetic heterogeneity of myopia. Linkage analysis placed a
gene for myopia susceptibility on chromosome 10q21.1, within
a 2.67 cM interval. Linkage was excluded to the candidate
gene regions for the Stickler syndromes, Marfan syndrome,
©2007 Molecular Vision Molecular Vision 2007; 13:229-36 <http://www.molvis.org/molvis/v13/a26/>
TABLE 3. OBSERVED SEQUENCE POLYMORPHISMS IN THE PROTOCADHERIN 15 (PCDH15) AND ZW10 INTERACTER (ZWINT) GENES
                                     nt at
                                    GenBank
                                    (minus        nt                       AA        Sample number
  Genes           Position          strand)     changes       dbSNP      changes    (red=affected)
---------   ---------------------   -------   -----------   ----------   -------   -----------------
   PCDH15
Exon 2       83 bp in Exon 2           T          T/G       rs11004439    Ser->    C009, 7256
                                                                          Ala
Intron 2     50 bp, 5' of Exon 3       T           G        rs10825347      -      C009, 7252, 7253
             50 bp, 5' of Exon 3       T          G/T       rs10825347      -      7254, 7245, 7251,
                                                                                   7274, 7256, 7257
Intron 3      4 bp, 3’of Exon3         A          A/G       Novel           -      7254, 7251
Intron 4     31 bp, 5’of Exon5         T          T/C       rs11594958      -      7256
Intron 7      9 bp, 5’of Exon8         C          C/T       rs10740579      -      C009, 7257, 7272
              9 bp, 5’of Exon8         C           T        rs10740579      -      7254, 7256
Exon 8        4 bp in Exonic           C          C/T       Novel         Ala->    C009
                                                                          Thr
Intron 9     57 bp, 3’of Exon8         T           G        rs10763098      -      7254
             57 bp, 3’of Exon8         T          G/T       rs10763098      -      C009, 7256, 7257,
                                                                                   7272
Intron 9     71 bp, of 5' Exon 9       G           A        Novel           -      7254, 7245
             71 bp, of 5' Exon 9       G          G/A       Novel           -      C009, 7256, 7257,
                                                                                   7252, 7251
Intron 13    23 bp, of3' Exon13        G          G/A       rs7093302       -      C009, 7256, 7257,
                                                                                   7252, 7274, 7251
Intron 14    43 bp, of5' Exon 15       -      Insertion A   Novel           -      C009, 7254, 7256,
                                                                                   7257, 7272
Intron 17   141 bp, 3' of Exon 17      C          C/T       Novel           -      7254, 7257
Intron 20    37 bp, 3' of Exon 20      C          C/T       Novel           -      7256, 7272
Exon 21      35 bp in Exon 21          G          G/A       rs2135720     Ile->    7256, 7272
                                                                          Ile
Intron 21   109 bp, 5' of Exon 22      T          T/C       Novel           -      C009, 7254
Intron 22    48 bp, 5' of Exon 23      G          G/A       rs2593107       -      C009, 7254
Intron 25    72 bp, 5' of Exon 26      A          A/G       Novel           -      C009, 7254
Intron 25    68 bp, 5' of Exon 26      T          T/G       Novel           -      7254, 7257
Intron 29    20 bp, 5' of Exon 30      C          C/T       Novel           -      C009, 7254,
                                                                                   7256, 7257,
                                                                                   7272
Intron 31   188 bp, 3' Exon 31         C          C/T       Novel           -      C009, 7254, 7256,
                                                                                   7257, 7272
Intron 32   120 bp, 3' of Exon 33      T          T/C       Novel           -      C009, 7254, 7256,
                                                                                   7257, 7272
Exon 33     215 bp, of Exon 33         C          C/A       Novel         Leu->    7256, 7272
                                                                          Leu
   ZWINT
Intron5      30 bp, 5' of Exon 4       C          C/T       Novel           -      7254, 7257
Intron 3     74 bp, 3' of Exon 3       G          A/A       rs3861049       -      C009, 7254, 7256,
                                                                                   7257, 7272
Affected individual sample numbers are in red. C009, external control; rs, public reference single nucleotide polymorphism (SNP) number
from the dbSNP database. Note: Samples C009, 7254, 7256, 7257, and 7272 were sequenced for all exons. Additional samples were se-
quenced for exons with polymorphisms that initially appeared to segregate with high-grade myopia.
234juvenile glaucoma, and Knobloch syndrome, ensuring that this
family did not exhibit a mild phenotypic expression of these
conditions. Similarly, linkage was excluded to known autoso-
mal myopia loci. Interestingly, two different haplotypes seg-
regate with high-grade myopia in this family, suggesting the
possibility that either the mutation is old and has recombined
into different genetic backgrounds (haplotypes), or two dis-
tinct mutations are responsible for the high-grade myopia seen
in this family.
A search for genes physically mapped between markers
D10S539 and D10S1767 revealed only two known genes:
PCDH15 (protocadherin 15) and ZWINT (ZW10 interactor).
PCDH15 is a member of the cadherin superfamily of calcium
dependent cell-cell adhesion molecules. A 15 cM region en-
compassing the PCDH15 gene region was initially implicated
in autosomal recessive Usher syndrome in a 1997 study of a
Hutterite family [39]. This region was further refined in a study
of two Pakistani families segregating Usher syndrome type
1F that demonstrated two homozygous mutations (splice site
acceptor mutation and nonsense mutation) in the 33 exon
PCDH15 gene [36]. Additional truncating mutations have since
been discovered in other individuals with Usher syndrome.
Usher syndrome is characterized by progressive pigmentary
retinopathy and sensorineural hearing loss, and individuals
with Usher syndrome type 1 have congenital severe-to-pro-
found hearing loss and vestibular dysfunction. Interestingly,
individuals with non-syndromic recessive hearing loss
(DFNB23) have been found to have missense mutations in
PCDH15 [40]. Immunohistochemistry has demonstrated that
PCDH15 is expressed in the photoreceptors, especially in the
outer photoreceptor segments of human and monkey retinas
[40]. Cones demonstrated strong immunoreactivity and rods
demonstrated a diffuse positive signal throughout the photo-
receptor layer [40].
ZWINT directly specifies the localization of ZW10 (Zeste
White 10) to kinetochores and is essential for mitotic check-
point signaling, as cells lacking ZWINT fail to arrest in mito-
sis when exposed to microtubule inhibitors, yielding interphase
cells with multinuclei [41]. Musio et al. [42] found that inhi-
bition of INCENP, ZWINT, and ZW10 resulted in mitotic cells
characterized by centromere separation, chromosome aneup-
loidy, and micronuclei formation, with chromosome morphol-
ogy similar to that found in Roberts syndrome. The profound
effects of ZWINT disruption made ZWINT a less compelling
candidate gene and gene expression patterns of ZWINT in ocu-
lar tissues are unknown.
Direct sequencing of the coding regions of either gene
did not reveal myopia-implicated mutations. Novel SNPs ob-
served with both genes were submitted to the NCBI dbSNP
database. Observed frequencies were submitted for known
SNPs. Though there are no other known genes in this region,
there is one predicted gene, AL834134, which encodes for the
hypothetical protein DKFZp667A1711 of unknown function.
We also cannot rule out the possibility of genetic hetero-
geneity within this family. As mentioned earlier, it appears
that the family is made of two distinct branches joined by
marriage, so it is quite possible that the 1p36.32-1p36.31 lo-
cus (LOD=1.330) is involved in the high-grade myopia of the
left branch of the family (affected haplotype with crosshatch-
ing) and the 10q21.1 locus is involved in the high-grade myo-
pia of the right branch (affected haplotype in solid black). The
small number of affected individuals in one branch may ex-
plain the lack of a significant LOD score for the 1p36.32-
1p36.31 locus.
In summary, we have mapped a presumptive genetic lo-
cus for high-grade myopia. Mutational characterization of the
remaining predicted gene in this region may provide additional
insight into the molecular mechanisms underlying the devel-
opment of high-grade myopia and into the regulation of eye
growth. However, it is important to note that certain assump-
tions have been made in the determination of this locus, and
further evidence of linkage of myopia to the 10q21.1 region
should be sought out.
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